Fertility Treatment and Cancers—The Eternal Conundrum: A Systematic Review and Meta-analysis. Issue 6 (June 2021) - Barcroft, Jennifer Frances
Abstract : (Abstracted from Hum Reprod 2021;36:1093–1107) Given the increased risk of ovarian, breast, and endometrial cancers associated with nulliparity, there is a higher inherent cancer risk among patients pursuing fertility treatment (FT) than the general population. Endometrial and breast are hormone-sensitive cancers that carry elevated risk associated with estrogen predominant states including ovarian stimulation.